ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 848

Nitroglycerin Patch Application in Systemic Sclerosis: Evaluation By Laser Doppler Imaging

Georgiana Bentea, Aurelien Wauters, Jean-Claude Wautrecht and Elie Cogan, Erasme Hospital, Brussels, Belgium

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Imaging, Raynaud's phenomenon, systemic sclerosis and treatment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Systemic sclerosis
(SSc) is a complex autoimmune disease, commonly associated with Raynaud
phenomenon (RP). The aim of this study was to characterize the microvascular
reactivity to nitroglycerin (NTG) patch application in SSc patients by Laser
Doppler imaging (LDI), and investigate predictive markers of the NTG response.

Methods:

The study included 21
SSc patients and 13 age-matched healthy volunteers. The SSc patients recruited
from Erasme Hospital, Brussels, Belgium, met the American College of Rheumatology
criteria for SSc, and presented with secondary RP. Blood flow was evaluated by
LDI, and expressed in perfusion units (PU), as well as the area under the
perfusion-time curve normalized for baseline flux (AUC). Microvascular morphology
was evaluated by nailfold capillaroscopy (NC). Baseline measurements were
complemented by dynamic studies analyzing microvascular function following
application of a NTG 5mg/24h patch (left hand metacarpus, during 120 min).
Subjects also underwent a cold challenge (both hands, 1 min at 15oC)
in the absence of, and following NTG application.

Results:

LDI measurements
revealed decreased fingertip baseline perfusion in SSc patients compared to
control. Moreover, SSc patients demonstrated a stronger vasoconstrictor
response to a cold challenge, at both hands (Fig 1A).

Figure 1.

Metacarpal application
of NTG patch led to an increase in blood flow and hand temperature in SSc
patients but not in controls (Fig 1B, Fig 2). Furthermore, NTG administration led
to a faster reperfusion after cold challenge (Fig 1C).

Figure 2.

Correlations analyses
revealed that the magnitude of the vasodilatory response following NTG was
inversely related with baseline fingertip perfusion and hand temperature (Fig
3A, B), but unrelated with structural microvascular features assessed using NC
(Fig 3D).

Figure 3.

Conclusion:

We provide evidence of
a vasodilatory reaction following application of a NTG patch in SSc patients
using LDI. Furthermore, the magnitude of the response to NTG was related with
functional, but not structural, features. In particular, SSc patients that
showed decreased baseline condition (lower fingertip perfusion and hand
temperature) benefited the most after NTG application. Our results support a further
evaluation of the NTG patch as a possible effective treatment for SSc-associated
RP.

 


Disclosure: G. Bentea, None; A. Wauters, None; J. C. Wautrecht, None; E. Cogan, None.

To cite this abstract in AMA style:

Bentea G, Wauters A, Wautrecht JC, Cogan E. Nitroglycerin Patch Application in Systemic Sclerosis: Evaluation By Laser Doppler Imaging [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/nitroglycerin-patch-application-in-systemic-sclerosis-evaluation-by-laser-doppler-imaging/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nitroglycerin-patch-application-in-systemic-sclerosis-evaluation-by-laser-doppler-imaging/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology